seri
benzoxazinon
synthes
subject
antihuman
coronaviru
express
inhibit
assay
among
compound
exhibit
signific
antihcov
activ
ic
valu
compound
lgml
respect
furthermor
compound
show
signific
inhibitori
effect
express
ed
valu
lgml
respect
benzoxazinon
analogu
antihuman
coronaviru
antihcov
express
inhibit
agent
human
coronavirus
hcov
major
caus
upper
respiratori
tract
ill
human
recent
novel
hcov
found
induc
sever
acut
respiratori
syndrom
sar
action
spike
protein
coronaviru
mediat
infect
target
cell
patient
sarsassoci
coronaviru
infect
could
develop
atyp
pneumonia
fulmin
pulmonari
edema
addit
peopl
die
diseas
last
two
year
therefor
research
develop
antihcov
agent
import
way
control
diseas
gener
three
target
develop
antivir
agent
inhibitor
viru
entri
membran
fusion
proteas
inhibitor
inhibit
cleavag
viral
polymeras
protein
viral
rna
synthesi
nucleosid
inhibitor
block
viral
replic
among
inhibitor
hcov
sarscov
proteinas
antihcov
agent
attract
target
treat
sar
therefor
proteas
sabadinin
natur
product
isol
veratrum
sabadilla
consid
inhibitor
sarscov
proteinas
base
comput
model
evalu
addit
glycyrrhizin
natur
compon
tradit
chines
medicin
glycyrrhiza
uralensi
demonstr
inhibit
replic
sarscov
hand
hcov
associ
virus
usual
induc
pulmonari
inflamm
inflamm
induc
viru
key
event
leukocyt
extravas
endothelium
local
activ
endotheli
cell
indic
express
adhes
molecul
intercellular
adhes
molecul
vascular
cell
adhes
molecul
eselectin
therefor
research
antihcov
antiinflammatori
agent
natur
sourc
deriv
found
dianthranthramid
deriv
benzoxazinon
exhibit
antihcov
antiinflammatori
effect
dianthramid
phytoalexin
isol
dianthu
speci
caryophyllacea
plant
infect
phytophthora
parasitica
carboxyl
function
anthranil
acid
dianthramid
skeleton
free
dianthramid
methylesterifi
dianthramid
b
implic
benzoxazinon
heterocycl
dianthalexin
fig
among
analogu
exhibit
vitro
antifung
activ
p
parasitica
benzoxazinon
also
known
mechanismbas
inhibitor
standard
serin
proteas
chymotrypsin
superfamili
inhibit
format
acylenzym
complex
attack
activ
site
serin
carbonyl
group
therefor
benzoxazinon
show
bioactiv
human
leukocyt
elastas
serin
proteas
complement
system
cathepsin
g
human
chymas
tissu
factor
viia
furthermor
interest
benzoxazinon
could
also
virtual
proteas
inhibitor
herp
simplex
viru
type
proteas
hcmv
proteas
mention
tri
research
develop
benzoxazinon
antihcov
agent
fortun
found
analogu
benzoxazinon
exhibit
signific
effect
hcov
report
prepar
preliminari
screen
data
antihcov
express
inhibit
benzoxazinon
analogu
fig
deriv
compound
prepar
reaction
acid
correspond
substitut
benzoyl
chlorid
compound
synthes
reaction
acid
acid
correspond
substitut
benzoyl
chlorid
product
fulli
character
use
spectral
data
h
nmr
uv
ir
ms
pharmacolog
evalu
discuss
seventi
microlit
cell
human
fibroblast
cell
cellsml
fbsdmem
medium
cultur
plate
incub
h
hcov
strain
tcid
well
ad
incub
h
ten
microlit
drug
ad
triplic
variou
concentr
xtt
assay
use
determin
level
cell
viabil
day
incub
actinomycin
use
posit
control
assay
perform
use
method
describ
previous
synthes
analogu
test
parallel
actinomycin
hcov
data
summar
tabl
activ
compound
test
express
assay
advanc
among
compound
exhibit
signific
inhibit
activ
activ
ed
lgml
respect
furthermor
compound
inact
ed
lgml
accord
result
structureact
relationship
could
propos
chloroand
benzoxazinon
show
signific
inhibitori
effect
express
orthoand
metahalogen
substitut
analogu
activ
conclus
compound
exhibit
signific
activ
human
coronaviru
moreov
compound
also
show
impress
effect
inhibit
express
first
report
benzoxazin
inhibitor
also
serv
antihcov
agent
result
propos
lead
compound
research
develop
antihcov
inhibit
agent
